GRI Bio Inc.

NASDAQ: GRI · Real-Time Price · USD
1.40
-0.04 (-2.78%)
At close: Aug 15, 2025, 3:59 PM
1.44
2.86%
After-hours: Aug 15, 2025, 07:46 PM EDT

GRI Bio Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
5.03M 1.81M 9K 3.7M
Short-Term Investments
n/a n/a n/a 3.81M
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a n/a
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
587K 1.13M 303K 619K
Total Current Assets
5.62M 2.93M 312K 8.13M
Property-Plant & Equipment
124K 22K 71K 206K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
124K 22K 71K 206K
Total Assets
5.74M 2.96M 383K 8.34M
Account Payables
897K 1.41M 1.29M 57K
Deferred Revenue
n/a n/a 5K 62K
Short-Term Debt
n/a 14K 602K 97K
Other Current Liabilities
354K 537K 60K 1.03M
Total Current Liabilities
1.64M 2.7M 1.99M 2.44M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a 5K
Total Long-Term Liabilities
71K n/a 14K 72K
Total Liabilities
1.71M 2.7M 2.01M 2.52M
Total Debt
119K 14K 673K 169K
Common Stock
n/a n/a 1K n/a
Retained Earnings
-39.74M -31.53M -18.5M -21.9M
Comprehensive Income
n/a n/a n/a -2K
Shareholders Equity
4.03M 259K -1.63M 5.82M
Total Investments
n/a n/a n/a 3.81M